CBS reveals US expansion plans and ambitions to harness post-antibiotic opportunities
Anchored by the opening of a distribution center in Volga, South Dakota, the launch of CBS America will support the company’s expansion in the US. CBS has particular ambitions to develop the market for bio-based liquid systems that can help livestock producers reduce their reliance on antibiotics.
CBS has serviced the US for many years via distribution partners, and reports that over the past decade, the market has “steadily grown in importance” for its feed science solutions business.
“Industry trends have supported rising demand for many of the bio-based, science-driven innovations we have pioneered. We have seen an outstanding market response including double digit growth in the US for the past two years,” Krisjan Jones, operations director at CBS Inc, told FeedNavigator.
CBS says that the launch of CBS America and the opening of the distribution center will give its US distribution partners and customers “more efficient access” to these feed products.
Emphasis on bio-based liquid production
Among the next steps will be the expansion of CBS’ liquid production capabilities, according to Jones.
“The expansion of liquid production of our solutions is part of our roll-out of new on-farm [technology] that fits well in the new post-antibiotic regulatory environment,” he said.
This follows the launch earlier this year of the company’s yeast bioactives technology in a new liquid format for use in water.
“We have seen a huge increase in adoption of this technology, first in Canada and now gaining traction in the US. It offers broad benefits as a bio-based, production-enhancing technology that gives livestock producers a much-needed option not only for optimizing efficiency and performance, but also as a health management tool.
“Producers are seeing visible improvements with this technology, including advantages for systems aimed at reducing reliance on antibiotics,” noted Jones.
CBS Yeast Bioactives is one of a number of new lines to have been added to the company’s offering of bio-based feed technology.
“Our portfolio has been newly expanded over the past two years to include new-generation updates of many of our tools as well as brand new categories of feed technology such as our new CBS Yeast Bioactives technology,” said Jones.
These solutions, designed to benefit swine, poultry, aquaculture and ruminant production, are marketed under the company’s five ‘Feed Science Platforms’, namely: Multi-Carbohydrase enzyme technology, enhanced yeast technology, grain management technology, functional fatty acids and phytogenetics and probiotics. All products under these platforms will be available from the new location.
Looking at the “bigger picture”, he said CBS’ strategy includes expanding overall production capacity to service both US and export markets.
Favorable conditions for growth
All of these developments are on the back of what CBS describes as “an extended period of strong expansion…fueled by broadening global opportunities”.
Expanding on this context, Jones said: “CBS Inc. was built largely on solutions that fit the trend towards natural ingredients and processes that add value at the farm gate level and provide science-based alternatives to conventional tools and approaches, such as those that relied more heavily on antibiotic use.
“The market shift, particularly over the past decade, has been a major factor in increased interest and demand for CBS products. Over this same period, we have made continued strong advances and innovations with our feed technology portfolio. The market evolution and technology advances have aligned to support the major growth we are experiencing in key markets, both domestically and internationally.”
